View of Efficacy and Safety of Original Versus Generic Erlotinib in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations in Thailand: A Retrospective Cohort Study

Return to Article Details Efficacy and Safety of Original Versus Generic Erlotinib in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations in Thailand: A Retrospective Cohort Study Download Download PDF